Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Simoneide Souza Titze-de-Almeida, Cristina Soto-Sánchez, Eduardo Fernández, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 841-841
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Jannik Prasuhn, Ryan L. Davis, Kishore R. Kumar
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 108
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 102
Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders
Sujay Paul, Luis Alberto Bravo-Vázquez, Samantha Pérez Uribe, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1698-1698
Open Access | Times Cited: 96
The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways
Ming‐Che Kuo, Sam Chi-Hao Liu, Ya-Fang Hsu, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 71
Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4610-4610
Open Access | Times Cited: 49
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 43
Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111800-111800
Closed Access | Times Cited: 24
Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis
Monika Sharma, Ankur Kumar Tanwar, Paresh Kumar Purohit, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105685-105685
Closed Access | Times Cited: 11
MicroRNAs in Parkinson’s disease: From pathogenesis to diagnostics and therapeutic strategies
Dongying Zheng, Jibing Chween
Neuroscience (2025)
Closed Access | Times Cited: 1
Roles of clock genes in the pathogenesis of Parkinson's disease
Anastasiia D. Shkodina, Shing Cheng Tan, Mohammad Mehedi Hasan, et al.
Ageing Research Reviews (2021) Vol. 74, pp. 101554-101554
Closed Access | Times Cited: 54
The Implications of ncRNAs in the Development of Human Diseases
Elena López‐Jiménez, Eduardo Andrés‐León
Non-Coding RNA (2021) Vol. 7, Iss. 1, pp. 17-17
Open Access | Times Cited: 53
Alzheimer’s Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target
Meng Zhang, Zhigang Bian
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 41
Parkinson’s Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy
Elena Paccosi, Luca Proietti‐De‐Santis
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9547-9547
Open Access | Times Cited: 20
Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics
Sai Nikhil Uppala, Kamatham Pushpa Tryphena, Padmashri Naren, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111826-111826
Closed Access | Times Cited: 19
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
Néha Datta, Charlotte Johnson, Dina Kao, et al.
Pharmacological Research (2023) Vol. 194, pp. 106870-106870
Open Access | Times Cited: 17
Targeting epigenetic modifications in Parkinson's disease therapy
Dan Zhang, Jifa Zhang, Yuxi Wang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1748-1777
Closed Access | Times Cited: 16
Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review)
Qingchun Lei, Tingting Wu, Jin Wu, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 4
Open Access | Times Cited: 37
Clinical progress of nanomedicine-based RNA therapies
Siyoung A. Lim, Alysia Cox, Madelynn Tung, et al.
Bioactive Materials (2021) Vol. 12, pp. 203-213
Open Access | Times Cited: 37
Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer
Osama Sweef, Elsayed Zaabout, Ahmed Bakheet, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2061-2061
Open Access | Times Cited: 14
microRNAs as molecular tools for brain health: Neuroprotective potential in neurodegenerative disorders
Mozhgan Abasi, Anvarsadat Kianmehr, Atena Variji, et al.
Neuroscience (2025)
Closed Access
The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
Marc van der Vlag, Robbert Havekes, Pim R.A. Heckman
European Journal of Neuroscience (2020) Vol. 52, Iss. 4, pp. 3256-3268
Open Access | Times Cited: 34
Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
Kamatham Pushpa Tryphena, Urati Anuradha, Rohith Kumar, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S187-S202
Open Access | Times Cited: 20
Competing endogenous RNA (ceRNA) networks in Parkinson's disease: A systematic review
Mohammad Reza Asadi, Samin Abed, Ghazal Kouchakali, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies
Riya Joshi, Hemi Missong, Jayapriya Mishra, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105067-105067
Closed Access | Times Cited: 11
Regulatory miRNA–mRNA Networks in Parkinson’s Disease
Bruno Lopes Santos‐Lobato, Amanda Vidal, Ândrea Ribeiro‐dos‐Santos
Cells (2021) Vol. 10, Iss. 6, pp. 1410-1410
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top